Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

NCT02400775 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02400775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02400775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2015
Completion date
April 30, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension with stable angina and dyslipidemia